News
IO Biotech was named to Fast Company’s World’s Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...
A new study published in Diabetes Technology & Therapeutics offers reassuring evidence that short-term use of automated ...
Artwork in children’s books brings layers to the story and does the work of capturing the big, small moments in kids’ lives, ...
8d
World Construction Network on MSNChina Medical University breaks ground on Museum of Fine Arts in TaiwanChina Medical University (CMU) has initiated the construction of a significant cultural landmark, the CMU Museum of Fine Arts ...
Initiation of AERIAL trial accelerated by successful first close of Series A1 financing LEU011 is first CAR-T candidate for the treatment of solid tumours to be manufactured ...
Nagpur: "Theatre allows us to express the unseen energies of the human mind while we enjoy the performance," said former ...
Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0 ...
This useful study explores the role of RAP2A in asymmetric cell division (ACD) regulation in glioblastoma stem cells (GSCs), drawing parallels to Drosophila ACD mechanisms and proposing that an ...
Collaboration supports manufacture of the OPTF01 product to Drive Next-Generation Chimeric Antigen Receptor T Cell (CAR-T) Development ...
François Ravenelle, PhD Appointed President and CEO of Innospera Pharma to Lead Next Phase of Growth
Innospera Pharma Inc. (“Innospera”), a private, near-clinical-stage biotechnology company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results